AFMC-AIMECS meetings are the most important international event organized by the Asian Federation for Medicinal Chemistry (AFMC) on the biennial years since its first meeting held in Japan in 1997. AFMC-AIMECS meetings provide a very important and beneficial opportunity for the medicinal chemists to stimulate the exchange of ideas, and to evaluate new methods and new lines of investigation for the contribution to the global progress of drug design and development.

Following the traditions of AFMC-AIMECS meetings, the 12th AIMECS 2019 will also provide an international forum for presentation and discussion, by both highly skilled professionals and young scientists from academia and/or industry by featuring invited lectures, oral talks and poster presentations of recent progress and future trends in all aspects of Medicinal Chemistry.

AFMC-AIMECS 2019 will include sessions organized by the American Chemical Society (ACS) Division of Medicinal Chemistry and the European Federation of Medicinal Chemistry (EFMC) as the participating organizations.

The Scientific Program of the Conference will include invited lectures, oral communications, and poster presentations and the scientific program will comprise parallel sessions in order to give chance to present the maximum number of oral communications for discussing on their participated fields.

To see the symposium related topics, please visit the Symposium webpage Programme/Topics section page; http://www.aimecs2019.org/topic

The symposium will focus on:

1. ADME Prediction and Computational Toxicology for Safer and Efficacious Drugs,
2. Advances in Synthetic Medicinal Chemistry,
3. Artificial Intelligence/Deep Learning in Drug Discovery,
4. Big Data Analysis, Cloud Resources and Precision Medicine,
5. Binding Kinetics in Drug Discovery,
6. Biomaterials and Drug Delivery,
7. Biopharmaceuticals
8. Biophysical Methods in High Throughput Screening in Drug Discovery,
9. Biotechnology Targeted Drugs,
10. Chemical Probes in Drug Discovery,
11. Cheminformatics / Pharmacoinformatics in the Era of Biological Complexity,
12. Computational Biology and Quantum Enzymology,
13. Design and Synthesis of Peptide-Based Compounds,
14. Drug Discovery for the Metabolic Syndrome and Associated Diseases,
15. Drugs from Natural Resources,
16. Epigenetic Drugs,
17. Gene Targeted Drugs,
18. G-protein-coupled Receptors (GPCRs) as Therapeutic Targets
19. Heterocyclic Compounds: Synthesis and Physicochemical Properties,
20. Ligand-Based and Structure-Based Approaches to Drug Design,
21. Medicinal Chemistry Approaches to Overcome Multi Drug Resistance in Cancer and Infectious Diseases,
22. Microwave Chemistry,
23. Miscellaneous Drugs,
24. Modulators for Inflammation and Immune System,
25. Multi-Target Drugs,
26. Nanotechnology in Drug Discovery,
27. New avenues in QSAR & QSPR Methodology and Applications,
28. Organic Halogen Compounds: Synthesis and Physicochemical Properties,
29. Parkinson’s Disease: Challenges and Opportunities,
    
30. Prodrugs,
31. Recent Advances in Developments of the Anticancer Agents,
32. Recent Developments in Novel Antiviral Agents,
33. Recent Developments in Novel Antipsychotic Drugs,
34. Recent Developments in Novel Herbal Drugs,
35. Regenerative Medicine: A new Area of Translational Science,
36. Stereochemical Control in Organic Synthesis,
37. Synthetic Chemistry,
38. Targeted Drug Delivery,
39. Targeting Protein-Protein Interactions and Protein Target Dynamics for Drug Discovery,
40. The Post-Antibiotic Era: Promising Developments in the Therapy of Infectious Diseases,